Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2020
Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström MacroglobulinemiaSteven P Treon, Kirsten Meid, Joshua Gustine, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 18, 2025
Dermatologic Adverse Events Following CD19-Directed CAR T-Cell Therapy in Hematologic MalignanciesRyan Storgard, Rachel E Reingold, Rose Parisi, et al.
Blood Neoplasia|June 24, 2025
CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomasPaola Ghione, Kurt S Bantilan, Erel Joffe, et al.
JCI Insight|April 3, 2019
Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLLMark B Geyer, Isabelle Rivière, Brigitte Sénéchal, et al.
Expert Review of Anticancer Therapy|February 1, 2023
A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphomaM Lia Palomba, Paola Ghione, Anik R Patel, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 16, 2024
A Comparison of 3-Year Follow-up of ZUMA-5 (Axicabtagene Ciloleucel) With SCHOLAR-5 in Relapsed/Refractory Follicular LymphomaPaola Ghione, M Lia Palomba, Markqayne D Ray, et al.
Blood|October 27, 2023
Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001Jeremy S Abramson, M Lia Palomba, Leo I Gordon, et al.
Haematologica|October 20, 2022
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 studyPaola Ghione, M Lia Palomba, Hervé Ghesquieres, et al.
Blood|February 26, 2017
Acquired mutations associated with ibrutinib resistance in Waldenström macroglobulinemiaLian Xu, Nicholas Tsakmaklis, Guang Yang, et al.
British Journal of Haematology|December 22, 2015
Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective studyJorge J Castillo, Shirley D'Sa, Michael P Lunn, et al.
Pageof 12